US FDA to require paediatric information in submissions
This article was originally published in RAJ Devices
A new rule issued by the US Food and Drug Administration will make it mandatory for medical device manufacturers seeking premarket approval of their products to provide “readily available” information on paediatric patients who suffer from the disease or condition that the device is intended to treat/diagnose/cure, even if the device is intended for adult use1.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.